Related Experiment Video
Updated: Apr 16, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Involvement of Bim in Photofrin-mediated photodynamically induced apoptosis
Xianwang Wang1, Xiaobing He, Shujuan Hu
1Laboratory of Neuronal Network and Brain Diseases Modulation, School of Medicine, Yangtze University, Jingzhou, China.
Background/Aims:
Photodynamic therapy (PDT) is a promising noninvasive technique, which has been successfully applied to the treatment of human cancers. Studies have shown that the Bcl-2 family proteins play important roles in PDT-induced apoptosis. However, whether Bcl-2-interacting mediator of cell death (Bim) is involved in photodynamic treatment remains unknown. In this study, we attempt to determine the effect of Bim on Photofrin photodynamic treatment (PPT)-induced apoptosis in human lung adenocarcinoma ASTC-a-1 cells.
Methods:
The translocation of Bim/Bax of the cells were monitored by laser confocal scanning microscope. The levels of Bim protein and activated caspase-3 in cells were detected by western blot assay. Caspase-3 activities were measured by Caspase-3 Fluorogenic Substrate (Ac-DEVD-AFC) analysis. The induction of apoptosis was detected by Hoechst 33258 and PI staining as well as flow cytometry analysis. The effect of Bim on PPT-induced apoptosis was determined by RNAi.
Results:
BimL translocated to mitochondria in response to PPT, similar to the downstream pro-apoptotic protein Bax activation. PPT increased the level of Bim and activated caspase-3 in cells and that knockdown of Bim by RNAi significantly protected against caspase-3 activity. PPT-induced apoptosis were suppressed in cells transfected with shRNA-Bim.
Conclusion:
We demonstrated the involvement of Bim in PPT-induced apoptosis in human ASTC-a-1 lung adenocarcinoma cells and suggested that enhancing Bim activity might be a potential strategy for treating human cancers.
Insights
Bcl-2-interacting mediator of cell death (Bim) plays a role in photodynamic therapy (PDT)-induced apoptosis in lung cancer cells. Inhibiting Bim protected cells from PDT, suggesting Bim enhancement could be a cancer treatment strategy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Photodynamic therapy (PDT) is a noninvasive cancer treatment.
- Bcl-2 family proteins are crucial in PDT-induced apoptosis.
- The role of Bim in PDT-induced apoptosis was previously unknown.
Purpose of the Study:
- To investigate the effect of Bim on Photofrin photodynamic treatment (PPT)-induced apoptosis.
- To determine if Bim is involved in PPT-induced apoptosis in human lung adenocarcinoma cells.
Main Methods:
- Monitoring Bim/Bax translocation using laser confocal microscopy.
- Assessing Bim protein and activated caspase-3 levels via western blot.
- Measuring caspase-3 activity and apoptosis induction using various staining and flow cytometry techniques.
- Utilizing RNA interference (RNAi) to determine Bim's effect on PPT-induced apoptosis.
Main Results:
- PPT induced BimL translocation to mitochondria, similar to Bax activation.
- PPT increased Bim and activated caspase-3 levels.
- Knockdown of Bim significantly reduced caspase-3 activity and suppressed PPT-induced apoptosis.
Conclusions:
- Bim is involved in PPT-induced apoptosis in human lung adenocarcinoma cells.
- Enhancing Bim activity may represent a potential therapeutic strategy for human cancers.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway

